Atul Q3 FY26: consolidated PAT up 40% at Rs 163.54 cr, revenue rises 11%

Pat Growth 25pctExceptional ItemResults View source PDF Explain this filing

ATUL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹5781.00

prior close

₹5794.00

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.9%+3.3% vs market

Specialty Chemicals peers, median of 86sector-1.3%+2.7% vs sector

On the reaction day the stock moved 3.3 pts more than Nifty Smallcap 250 and 2.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.1

10m

+0.5

15m

+1.5

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.4-1.9+3.3-1.3+2.7

Next day

+1.0-1.7+2.8-2.2+3.2

+6.6+0.1+6.5-0.9+7.5

+7.1+0.1+7.0-1.0+8.1

+7.8+0.9+6.9-0.2+8.1

+3.2-0.7+3.9-0.4+3.5

+8.8+3.0+5.8+2.2+6.6

15d

+13.1+2.3+10.8+0.9+12.3

+12.5+2.6+9.9-1.5+14.0

+4.7-8.9+13.5-11.6+16.2

+15.8+6.2+9.6+2.4+13.3

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 86Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Atul reported Q3 FY26 consolidated revenue of Rs 1,573.62 cr, up 11% YoY. PAT jumped 40% to Rs 163.54 cr. For 9M FY26, revenue rose 11% to Rs 4,603.47 cr and PAT grew 30% to Rs 478.27 cr. Standalone Q3 PAT was Rs 121.15 cr, up 31%. Results include a one-time Rs 36.61 cr (standalone) and Rs 41.35 cr (consolidated) provision for new labour codes. Auditors gave an unmodified limited review.

Likely market impact

Strong profit growth shows margin expansion; one-time labour code provision is a near-term drag but underlying earnings momentum is healthy for shareholders.